Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug Points: Cholestatic hepatitis in association with celecoxib.

Literature DB >> 11440939

Drug Points: Cholestatic hepatitis in association with celecoxib.

J P O'Beirne¹, S R Cairns.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2001 PMID： 11440939 PMCID： PMC34328 DOI： 10.1136/bmj.323.7303.23

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

5 in total

1. Celecoxib-induced acute pancreatitis and hepatitis: a case report.

Authors: R Carrillo-Jimenez; M Nurnberger
Journal: Arch Intern Med Date: 2000-02-28

2. COX 2 inhibitor and fulminant hepatic failure.

Authors: P A McCormick; F Kennedy; M Curry; O Traynor
Journal: Lancet Date: 1999-01-02 Impact factor: 79.321

Review 3. The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.

Authors: W C Maddrey; C J Maurath; K M Verburg; G S Geis
Journal: Am J Ther Date: 2000-05 Impact factor: 2.688

4. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors: F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal: JAMA Date: 2000-09-13 Impact factor: 56.272

5. Diclofenac associated hepatitis.

Authors: T J Iveson; N G Ryley; P M Kelly; J M Trowell; J O McGee; R W Chapman
Journal: J Hepatol Date: 1990-01 Impact factor: 25.083

5 in total

7 in total

1. Case of cholestatic hepatitis with celecoxib did not fulfil international criteria.

Authors: Felix M Arellano; Sean Z Zhao; Matthew W Reynolds
Journal: BMJ Date: 2002-03-30

2. Cholestatic hepatitis in association with celecoxib. Classification of drug associated liver dysfunction is questionable.

Authors: Faiyaz Mohammed; Alastair D Smith
Journal: BMJ Date: 2002-07-27

Drug Points: Cholestatic hepatitis in association with celecoxib.

1. Celecoxib-induced acute pancreatitis and hepatitis: a case report.

2. COX 2 inhibitor and fulminant hepatic failure.

Review 3. The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.

4. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

5. Diclofenac associated hepatitis.

1. Case of cholestatic hepatitis with celecoxib did not fulfil international criteria.

2. Cholestatic hepatitis in association with celecoxib. Classification of drug associated liver dysfunction is questionable.

3. Acute cholestatic hepatitis associated with long-term use of rofecoxib.

4. Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

5. Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation.

Review 6. COX-2 inhibitors: a CLASS act or Just VIGORously promoted.

7. Cholestatic hepatitis with small duct injury associated with celecoxib.